GlobeStar Therapeutics Corp Quarterly Interest Expense in USD from Q4 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
GlobeStar Therapeutics Corp quarterly/annual Interest Expense history and growth rate from Q4 2012 to Q2 2024.
  • GlobeStar Therapeutics Corp Interest Expense for the quarter ending June 30, 2024 was $4.3K, a 56.8% decline year-over-year.
  • GlobeStar Therapeutics Corp Interest Expense for the twelve months ending June 30, 2024 was $82.4K, a 95.3% increase year-over-year.
  • GlobeStar Therapeutics Corp annual Interest Expense for 2023 was $91.6K, a 30.2% increase from 2022.
  • GlobeStar Therapeutics Corp annual Interest Expense for 2022 was $70.3K, a 75.5% decline from 2021.
  • GlobeStar Therapeutics Corp annual Interest Expense for 2021 was $287K, a 20.8% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $82.4K $4.3K -$5.67K -56.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-10-11
Q1 2024 $88K $7.38K -$799 -9.77% Jan 1, 2024 Mar 31, 2024 10-Q 2024-06-28
Q4 2023 $88.8K $7.89K -$2.78K -26.1% Oct 1, 2023 Dec 31, 2023 10-Q 2024-03-12
Q3 2023 $91.6K $62.8K +$49.4K +370% Jul 1, 2023 Sep 30, 2023 10-K 2024-01-19
Q2 2023 $42.2K $9.97K -$694 -6.51% Apr 1, 2023 Jun 30, 2023 10-Q 2024-10-11
Q1 2023 $42.9K $8.18K -$18.1K -68.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-06-28
Q4 2022 $60.9K $10.7K -$9.42K -46.9% Oct 1, 2022 Dec 31, 2022 10-Q 2024-03-12
Q3 2022 $70.3K $13.3K -$61.5K -82.2% Jul 1, 2022 Sep 30, 2022 10-K 2024-01-19
Q2 2022 $132K $10.7K -$24.3K -69.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-17
Q1 2022 $156K $26.2K -$87.4K -76.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-31
Q4 2021 $244K $20.1K -$44K -68.6% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q3 2021 $287K $74.8K +$29.9K +66.6% Jul 1, 2021 Sep 30, 2021 10-K 2023-01-09
Q2 2021 $258K $34.9K -$4.47K -11.3% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-08-23
Q1 2021 $262K $114K +$46.7K +69.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-06-01
Q4 2020 $215K $64K -$22.8K -26.2% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $238K $44.9K -$75.8K -62.8% Jul 1, 2020 Sep 30, 2020 10-K 2022-01-05
Q2 2020 $314K $39.4K -$13.4K -25.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 $327K $66.9K -$36.3K -35.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-21
Q4 2019 $364K $86.8K +$3.27K +3.91% Oct 1, 2019 Dec 31, 2019 10-Q 2021-01-28
Q3 2019 $360K $121K +$35.7K +42% Jul 1, 2019 Sep 30, 2019 10-K 2020-12-03
Q2 2019 $325K $52.8K +$39.6K +300% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-14
Q1 2019 $285K $103K +$99.2K +2469% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $186K $83.5K +$82.3K +6833% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q3 2018 $103K $85K -$291K -77.4% Jul 1, 2018 Sep 30, 2018 10-K 2019-12-31
Q2 2018 $395K $13.2K -$90.2K -87.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $485K $4.02K -$71.5K -94.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $556K $1.21K -$79.4K -98.5% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-19
Q3 2017 $636K $376K Jul 1, 2017 Sep 30, 2017 10-K 2019-01-03
Q2 2017 $103K +$43.8K +73.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $75.5K -$37.7K -33.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 $80.6K +$4.59K +6.04% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-15
Q2 2016 $295K $59.7K -$344 -0.57% Apr 30, 2016 Jun 30, 2016 10-Q/A 2017-08-23
Q1 2016 $295K $113K -$41.1K -26.6% Jan 1, 2016 Mar 31, 2016 10-Q/A 2016-06-16
Q4 2015 $336K $76K -$51.4K -40.4% Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-22
Q3 2015 $388K $46.1K -$123K -72.8% Jul 1, 2015 Sep 30, 2015 10-K/A 2016-01-22
Q2 2015 $511K $60K -$296K -83.1% Apr 1, 2015 Jun 30, 2015 10-Q/A 2015-09-24
Q1 2015 $807K $154K +$87.7K +131% Jan 1, 2015 Mar 31, 2015 10-Q/A 2016-06-16
Q4 2014 $719K $127K -$68.2K -34.9% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-22
Q3 2014 $788K $169K +$61.7K +57.3% Jul 1, 2014 Sep 30, 2014 10-K/A 2016-01-22
Q2 2014 $726K $356K +$300K +538% Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-09-24
Q1 2014 $426K $66.8K -$33.8K -33.6% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-09-17
Q4 2013 $460K $196K +$159K +431% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 $301K $108K Jul 1, 2013 Sep 30, 2013 10-K/A 2015-01-27
Q2 2013 $55.8K Apr 1, 2013 Jun 30, 2013 10-Q/A 2014-09-04
Q1 2013 $101K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-20
Q4 2012 $36.9K Oct 1, 2012 Dec 31, 2012 10-Q/A 2014-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.